Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis

PHASE3CompletedINTERVENTIONAL
Enrollment

2,054

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions
Esophagitis, RefluxEsophagitis, Peptic
Interventions
DRUG

Dexlansoprazole MR

Dexlansoprazole MR 60 mg, capsules, orally, once daily (QD) for up to 8 weeks.

DRUG

Dexlansoprazole MR

Dexlansoprazole MR 90 mg, capsules, orally, once daily for up to 8 weeks.

DRUG

Lansoprazole

Lansoprazole 30 mg, capsules, orally, once daily for up to 8 weeks.

Trial Locations (144)

Unknown

Anniston

Hueytown

Huntsville

Tallassee

Tuscaloosa

Tucson

Little Rock

North Little Rock

Azusa

Carmichael

Cypress

Fresno

Los Angeles

Modesto

Newport Beach

Oakland

Orange

San Diego

Santa Maria

Littleton

Longmont

Wheat Ridge

Bristol

Newark

Fort Myers

Miami

Naples

New Smyrna Beach

Ocala

Pembroke Pines

Port Orange

Sarasota

St. Petersburg

Zephyrhills

Atlanta

Boise

Moline

North Chicago

Oak Forest

Evansville

Indianapolis

Newburgh

Davenport

Kansas City

Wichita

Lexington

Louisville

Baton Rouge

Chevy Chase

Prince Frederick

Jackson

Jefferson City

Kansas City

St Louis

Missoula

Egg Harbor

Albuquerque

Chapel Hill

Charlotte

Greensboro

Harrisburg

High Point

Raleigh

Wilmington

Winston-Salem

Bismarck

Akron

Columbus

Dayton

Mogadore

Oklahoma City

Medford

Portland

Philadelphia

Warwick

Anderson

Mt. Pleasant

Sioux Falls

Chattanooga

Germantown

Jackson

Johnson City

Kingsport

Amarillo

Conroe

Dallas

Fort Worth

Houston

Odessa

Pharr

Seguin

Temple

Salt Lake City

Charlottesville

Norfolk

Richmond

Bellevue

Lakewood

Tacoma

Milwaukee

Adelaide

Bedford Park

Kippa-Ring

Sofia

Hamilton

Newmarket

Montreal

Saskatoon

Cundinamarca

Barranquilla - Atlantico

Hradec Králové

Ostrava - Hrabuvka

Stuttgart

Bochum

Berlin

Bratislava

Hyderabad

Bangalore

Ludhiana

Hyderabad

Pune

Hamburg

Balvi

Riga

Valmiera

Panevezys

Vinius

Auckland

Lima

Bialystok

Bydgoszcz

Krakow

Mangalore

Warsaw

Moscow

Saint Petersburg

Yaroslavi

Daugavpils

Košice

Prešov

Bloemfontein

Cape Town

Observatory, Cape Town

Parktown, Gauteng

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY